arrow_back Back to App

Support for APS Testing in Pregnancy: Reducing Miscarriages, Saving Babies.

The U.S. House of Representatives supports including antiphospholipid syndrome (APS) testing as a standard part of prenatal screening. This aims to reduce the risk of miscarriages and other pregnancy complications, potentially bringing relief to many families and increasing the chances of a healthy birth.
Key points
Support for making APS testing a standard part of prenatal screening, which can help detect the condition early in pregnancy.
Call for medical associations to update their recommendations to include APS testing as a standard part of prenatal care.
Potential reduction in miscarriages and stillbirths through early detection and treatment of APS, benefiting maternal and child health.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_685
Sponsor: Rep. Cammack, Kat [R-FL-3]
Process start date: 2025-09-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_685.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-09.

What are the main provisions?

Key points include:

  • Support for making APS testing a standard part of prenatal screening, which can help detect the condition early in pregnancy.
  • Call for medical associations to update their recommendations to include APS testing as a standard part of prenatal care.
  • Potential reduction in miscarriages and stillbirths through early detection and treatment of APS, benefiting maternal and child health.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Cammack, Kat [R-FL-3].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

CATEGORIES

Health Family